SEC
SlamSEC
SearchBrowseEarnings

Immuron Ltd

Nasdaq:IMRN
Pharmaceutical Preparations·CARLTON, VICTORIA, C3
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Governanceproxy statements · beneficial ownership

Ownership Filings

7 shown
FiledFormDescription
1/7/21SC 13G/ASABBY 13G-A IMRN 1.07.21→
8/4/20SC 13DSC 13D→
7/21/20SC 13GSABBY 13G IMRN 7.21.20→
1/15/20SC 13G/AIMMURON LIMITED→
1/29/19SC 13G/AIMMURON LIMITED→
3/20/18SC 13GIMMURON LIMITED→
↓

Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.